Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

New trial data showed CagriSema led to “superior” weight loss, but at a rate much less than original expectations of 25%.

Impressions Face + Body owner says he's noticed a spike in interest from clients hoping to get face and body-lifts offered ...

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

Season three of The White Lotus is causing waves, especially for its uneasy female friend group. The three women at the ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

BRINP2-related peptide, or BRP, is a naturally occurring molecule that can suppress appetite and promote weight loss in mice ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Research suggests potential health benefits beyond what popular diabetes and weight-loss drugs were first approved to treat.

Like Aly, Abdul-Rahman also stresses that GLP-1 medications are a treatment for diabetes and obesity, and as such, they do ...

Ozempic and other GLP-1 drugs like it have become so pervasive in the zeitgeist that it’s likely even your most social ...